Whittier Trust’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-271
Closed -$5K 1668
2019
Q3
$5K Buy
+271
New +$3.1K ﹤0.01% 1268

Whittier Trust's ALDR Position: Q4 2019 in Review

Whittier Trust sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 271 shares — an estimated $5K sold.

Whittier Trust first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $5K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Whittier Trust reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Whittier Trust sold 271 Alder Biopharmaceuticals shares in Q4 2019, an estimated $5K.
  • Whittier Trust first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
  • Whittier Trust's Alder Biopharmaceuticals position peaked at $5K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Whittier Trust's 13F filing for Q4 2019, filed 31 Jan 2020.